Marc Lemonnier

1.3k total citations
42 papers, 969 citations indexed

About

Marc Lemonnier is a scholar working on Molecular Biology, Genetics and Molecular Medicine. According to data from OpenAlex, Marc Lemonnier has authored 42 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 17 papers in Genetics and 8 papers in Molecular Medicine. Recurrent topics in Marc Lemonnier's work include Bacterial Genetics and Biotechnology (16 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacteriophages and microbial interactions (7 papers). Marc Lemonnier is often cited by papers focused on Bacterial Genetics and Biotechnology (16 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacteriophages and microbial interactions (7 papers). Marc Lemonnier collaborates with scholars based in France, Spain and United Kingdom. Marc Lemonnier's co-authors include Ramón Díaz‐Orejas, David Lane, Emmanuel Lemichez, Sandra Santos‐Sierra, Marc Fiszman, Luce Landraud, Alfredo Berzal‐Herranz, Domenico Libri, Thierry Meinnel and Jean‐Yves Bouet and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Marc Lemonnier

42 papers receiving 954 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Lemonnier France 18 512 332 232 195 159 42 969
Christine Jacobs United States 13 691 1.3× 503 1.5× 309 1.3× 201 1.0× 148 0.9× 16 1.2k
Sabine Hunke Germany 17 624 1.2× 419 1.3× 192 0.8× 133 0.7× 182 1.1× 25 1.2k
Catherine Paradis‐Bleau Canada 15 718 1.4× 402 1.2× 249 1.1× 330 1.7× 141 0.9× 18 1.1k
Allister Crow United Kingdom 19 675 1.3× 250 0.8× 214 0.9× 91 0.5× 90 0.6× 27 1.2k
Minsang Shin South Korea 21 715 1.4× 349 1.1× 270 1.2× 224 1.1× 276 1.7× 75 1.3k
Raffaele Ieva France 19 887 1.7× 520 1.6× 131 0.6× 201 1.0× 253 1.6× 31 1.3k
Rachna Chaba India 12 1.1k 2.1× 687 2.1× 175 0.8× 232 1.2× 182 1.1× 21 1.5k
Michael D. Lundrigan United States 16 610 1.2× 456 1.4× 115 0.5× 171 0.9× 115 0.7× 22 923
Gioacchino Micheli Italy 21 871 1.7× 466 1.4× 147 0.6× 218 1.1× 375 2.4× 33 1.4k
Francis Biville France 22 786 1.5× 272 0.8× 97 0.4× 105 0.5× 85 0.5× 50 1.3k

Countries citing papers authored by Marc Lemonnier

Since Specialization
Citations

This map shows the geographic impact of Marc Lemonnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Lemonnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Lemonnier more than expected).

Fields of papers citing papers by Marc Lemonnier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Lemonnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Lemonnier. The network helps show where Marc Lemonnier may publish in the future.

Co-authorship network of co-authors of Marc Lemonnier

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Lemonnier. A scholar is included among the top collaborators of Marc Lemonnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Lemonnier. Marc Lemonnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zalacaín, Magdalena, Ian Morrissey, Stephen Hawser, et al.. (2024). Meropenem-ANT3310, a unique β-lactam-β-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 68(3). e0112023–e0112023. 6 indexed citations
2.
Zalacaín, Magdalena, Carole A. Sable, Marlène Murris, et al.. (2023). Higher levels of Pseudomonas aeruginosa LasB elastase expression are associated with early-stage infection in cystic fibrosis patients. Scientific Reports. 13(1). 14208–14208. 9 indexed citations
3.
Davies, David T., Jérôme Castandet, Michael S. Bodnarchuk, et al.. (2021). Virtual Screening Approach to Identifying a Novel and Tractable Series ofPseudomonas aeruginosaElastase Inhibitors. ACS Medicinal Chemistry Letters. 12(2). 217–227. 11 indexed citations
4.
Smith, Andrew, Elizabeth Diago‐Navarro, Lesley A. Mitchenall, et al.. (2012). A Common Origin for the Bacterial Toxin-Antitoxin Systems parD and ccd, Suggested by Analyses of Toxin/Target and Toxin/Antitoxin Interactions. PLoS ONE. 7(9). e46499–e46499. 17 indexed citations
5.
Visvikis, Orane, Laurent Boyer, Stéphanie Torrino, et al.. (2011). Escherichia coli Producing CNF1 Toxin Hijacks Tollip to Trigger Rac1‐Dependent Cell Invasion. Traffic. 12(5). 579–590. 40 indexed citations
6.
Diago‐Navarro, Elizabeth, Ana M. Hernández‐Arriaga, Monique B. Kamphuis, et al.. (2010). parD toxin–antitoxin system of plasmid R1 – basic contributions, biotechnological applications and relationships with closely‐related toxin–antitoxin systems. FEBS Journal. 277(15). 3097–3117. 28 indexed citations
7.
Baquero, Fernando & Marc Lemonnier. (2009). Generational coexistence and ancestor's inhibition in bacterial populations. FEMS Microbiology Reviews. 33(5). 958–967. 10 indexed citations
8.
Diago‐Navarro, Elizabeth, Liliana Mora, Richard H. Buckingham, Ramón Díaz‐Orejas, & Marc Lemonnier. (2008). Novel Escherichia coli RF1 mutants with decreased translation termination activity and increased sensitivity to the cytotoxic effect of the bacterial toxins Kid and RelE. Molecular Microbiology. 71(1). 66–78. 8 indexed citations
9.
Lemonnier, Marc, Luce Landraud, & Emmanuel Lemichez. (2007). Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiology Reviews. 31(5). 515–534. 76 indexed citations
10.
Kamphuis, Monique B., Maria Chiara Monti, Robert H. H. van den Heuvel, et al.. (2007). Interactions between the toxin Kid of the bacterial parD system and the antitoxins Kis and MazE. Proteins Structure Function and Bioinformatics. 67(1). 219–231. 27 indexed citations
11.
Kamphuis, Monique B., Alexandre M. J. J. Bonvin, Maria Chiara Monti, et al.. (2005). Model for RNA Binding and the Catalytic Site of the RNase Kid of the Bacterial parD Toxin–Antitoxin System. Journal of Molecular Biology. 357(1). 115–126. 42 indexed citations
12.
Lemonnier, Marc, et al.. (2005). RNase/Anti-RNase Activities of the BacterialparDToxin-Antitoxin System. Journal of Bacteriology. 187(9). 3151–3157. 38 indexed citations
13.
Relaix, Frédéric, Susanna Molinari, Marc Lemonnier, Beat W. Schäfer, & Margaret Buckingham. (2004). The in vivo form of the murine class VI POU protein Emb is larger than that encoded by previously described transcripts. Gene. 333. 35–46. 3 indexed citations
14.
Santos‐Sierra, Sandra, et al.. (2004). Insights into the specificity of RNA cleavage by the Escherichia coli MazF toxin. FEBS Letters. 567(2-3). 316–320. 78 indexed citations
15.
Lemonnier, Marc. (2003). Bacteriophage P1 Ban protein is a hexameric DNA helicase that interacts with and substitutes for Escherichia coli DnaB. Nucleic Acids Research. 31(14). 3918–3928. 17 indexed citations
16.
Lemonnier, Marc, Jean‐Yves Bouet, Virginie Libante, & D. Lane. (2000). Disruption of the F plasmid partition complex in vivo by partition protein SopA. Molecular Microbiology. 38(3). 493–503. 52 indexed citations
17.
Lemonnier, Marc, et al.. (1997). Genetic basis of the MbrC “ploidy” phenotype in Escherichia coli. Molecular and General Genetics MGG. 256(3). 291–297. 1 indexed citations
18.
19.
Maroteaux, P, et al.. (1978). [Mucolipidosis type I. Sialidosis due to alpha-2-6-neuraminidase deficiency with neurological symptoms].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(3). 280–91. 2 indexed citations
20.
Baumann, N, Marc Lemonnier, C. Jacque, et al.. (1975). Plasma galactocerebrosides in multiple sclerosis.. PubMed. 23(9). 387–90. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Jacobs Breakdown of academic impact, for papers by Sabine Hunke Breakdown of academic impact, for papers by Catherine Paradis‐Bleau Breakdown of academic impact, for papers by Allister Crow Breakdown of academic impact, for papers by Minsang Shin Breakdown of academic impact, for papers by Raffaele Ieva Breakdown of academic impact, for papers by Rachna Chaba Breakdown of academic impact, for papers by Michael D. Lundrigan Breakdown of academic impact, for papers by Gioacchino Micheli Breakdown of academic impact, for papers by Francis Biville
Rankless by CCL
2026